Search Results 231-240 of 16462 for Proliferation
Reduction in plasma cell proliferation after initial therapy in newly diagnosed multiple myeloma measures treatment response and predicts improved survival.
Cancer cells continue to grow and proliferate when they shouldn't. They cease their productive functions, and they take on dangerous new properties. And ...
“We are concerned that the proliferation of unregulated clinics could jeopardize stem cell therapy and regenerative medicine in the United States. The issue ...
... proliferative DR (NPDR) and no CI-DME at baseline. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and ...
Platelets count ≥ 450 x 10 to 9/L · Megakaryocyte proliferation with large and mature morphology. · Not meeting WHO criteria for CML, PV, MDS, PMF or over ...
... proliferation. ABC294640 also inhibits proliferation and induces apoptosis of cholangiocarcinoma cell lines. Furthermore, in a recent Phase I trial ...
Guerrero Cazares' research team conducts in vitro, in vivo and ex vivo studies on glioblastoma multiforme — the most common, aggressive and proliferative ...
Abeykoon does active research on exploiting other pathways associated with DNA damage and cell proliferation. He strives to bring new and efficacious ...
The proliferation center microenvironment and prognostic markers in chronic lymphocytic leukemia/small lymphocytic lymphoma. Hum Pathol. 2006 Feb; 37(2):152-9.
Subjects with proliferative and/or vascular retinopathy;; Subjects with known active liver disease (alcoholic, drug/toxin induced, genetic, or autoimmune) ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.